BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang H, Bai X. Mechanisms of Bone Remodeling Disorder in Hemophilia. Semin Thromb Hemost 2021;47:43-52. [PMID: 33368119 DOI: 10.1055/s-0040-1718890] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Lin X, Gao P, Zhang Q, Jiang Y, Wang O, Xia W, Li M. Pathogenesis and treatment of osteoporosis in patients with hemophilia. Arch Osteoporos 2023;18:17. [PMID: 36598583 DOI: 10.1007/s11657-022-01203-9] [Reference Citation Analysis]
2 Pai YY, Wang JD, Ho HE, Chou YJ, Ho WC, Chan WC, Chu WM, Tsan YT. Risk of Fractures, Repeated Fractures and Osteoporotic Fractures among Patients with Hemophilia in Taiwan: A 14-Year Population-Based Cohort Study. Int J Environ Res Public Health 2022;20. [PMID: 36612847 DOI: 10.3390/ijerph20010525] [Reference Citation Analysis]
3 Kiialainen A, Niggli M, Kempton CL, Castaman G, Chang T, Paz-Priel I, Adamkewicz JI, Levy GG. Effect of emicizumab prophylaxis on bone and joint health markers in people with haemophilia A without factor VIII inhibitors in the HAVEN 3 study. Haemophilia 2022;28:1033-43. [PMID: 35905294 DOI: 10.1111/hae.14642] [Reference Citation Analysis]
4 Shima M. Bispecific antibodies for the treatment of hemophilia A. Expert Opin Biol Ther 2021;:1-14. [PMID: 34098819 DOI: 10.1080/14712598.2021.1940133] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Favaloro EJ, Lippi G. Editorial Compilation IX. Semin Thromb Hemost 2021;47:6-10. [PMID: 33525039 DOI: 10.1055/s-0040-1721751] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]